Your browser doesn't support javascript.
loading
Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial.
Wunderink, Richard G; Giamarellos-Bourboulis, Evangelos J; Rahav, Galia; Mathers, Amy J; Bassetti, Matteo; Vazquez, Jose; Cornely, Oliver A; Solomkin, Joseph; Bhowmick, Tanaya; Bishara, Jihad; Daikos, George L; Felton, Tim; Furst, Maria Jose Lopez; Kwak, Eun Jeong; Menichetti, Francesco; Oren, Ilana; Alexander, Elizabeth L; Griffith, David; Lomovskaya, Olga; Loutit, Jeffery; Zhang, Shu; Dudley, Michael N; Kaye, Keith S.
Afiliação
  • Wunderink RG; Division of Pulmonary and Critical Care, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. r-wunderink@northwestern.edu.
  • Giamarellos-Bourboulis EJ; 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
  • Rahav G; Infectious Disease Unit and Laboratories, Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Mathers AJ; Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA, USA.
  • Bassetti M; Infectious Diseases Clinic, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
  • Vazquez J; Division of Infectious Diseases, Medical College of Georgia/Augusta University, Augusta, GA, USA.
  • Cornely OA; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Zentrum für klinische Studien (ZKS Köln), and Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
  • Solomkin J; Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Bhowmick T; Division of Allergy, Immunology, and Infectious Diseases, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
  • Bishara J; Infectious Disease Unit, Rabin Medical Center, Beilinson Hospital and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Daikos GL; First Department of Medicine, National and Kapodistrian University of Athens, Laiko Hospital, Athens, Greece.
  • Felton T; University Hospital of South Manchester and Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK.
  • Furst MJL; Unidad de Infectología, Sanatorio Municipal Dr. Julio Méndez, Buenos Aires, Argentina.
  • Kwak EJ; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Menichetti F; Dipartimento di gastroenterologia e malattie infettive, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Oren I; Infectious Diseases Unit, Rambam Health Care Campus, Haifa, Israel.
  • Alexander EL; The Medicines Company, Parsippany, NJ, USA.
  • Griffith D; The Medicines Company, San Diego, CA, USA.
  • Lomovskaya O; The Medicines Company, San Diego, CA, USA.
  • Loutit J; The Medicines Company, San Diego, CA, USA.
  • Zhang S; The Medicines Company, Parsippany, NJ, USA.
  • Dudley MN; The Medicines Company, San Diego, CA, USA.
  • Kaye KS; Professor of Internal Medicine, Director of Clinical Research, Division of Infectious Diseases, University of Michigan Medical School, 5510A MSRB I, SPC 5680, 1150 W. Medical Center Drive, Ann Arbor, MI, 48109-5680, USA.
Infect Dis Ther ; 7(4): 439-455, 2018 Dec.
Article em En | MEDLINE | ID: mdl-30270406

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2018 Tipo de documento: Article